|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 30 September 2022, 17:58. The announcement is not marked as price sensitive, and is 90 page(s) in length and 2.01MB in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.011% short sold according to ASIC data. It was ranked the 629th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Annual Report to shareholders | 30 September 2022, 17:58 |
| Corporate Governance Statement | 30 September 2022, 17:58 |
| Notification regarding unquoted securities - CHM | 28 September 2022, 17:43 |
| Dr Stephanie H. Astrow appointed VP, Translational Sciences | 8 September 2022, 10:32 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 